BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 30776697)

  • 1. Gene mutational analysis in a cohort of Chinese children with unexplained epilepsy: Identification of a new KCND3 phenotype and novel genes causing Dravet syndrome.
    Wang J; Wen Y; Zhang Q; Yu S; Chen Y; Wu X; Zhang Y; Bao X
    Seizure; 2019 Mar; 66():26-30. PubMed ID: 30776697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
    Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
    Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome.
    Jiang T; Shen Y; Chen H; Yuan Z; Mao S; Gao F
    Medicine (Baltimore); 2018 Dec; 97(50):e13565. PubMed ID: 30558019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaicism of de novo pathogenic SCN1A variants in epilepsy is a frequent phenomenon that correlates with variable phenotypes.
    de Lange IM; Koudijs MJ; van 't Slot R; Gunning B; Sonsma ACM; van Gemert LJJM; Mulder F; Carbo EC; van Kempen MJA; Verbeek NE; Nijman IJ; Ernst RF; Savelberg SMC; Knoers NVAM; Brilstra EH; Koeleman BPC
    Epilepsia; 2018 Mar; 59(3):690-703. PubMed ID: 29460957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and de novo mutations in pediatric refractory epilepsy.
    Liu J; Tong L; Song S; Niu Y; Li J; Wu X; Zhang J; Zai CC; Luo F; Wu J; Li H; Wong AHC; Sun R; Liu F; Li B
    Mol Brain; 2018 Sep; 11(1):48. PubMed ID: 30185235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Diagnosis of Dravet Syndrome Using Next Generation Sequencing-Based Epilepsy Gene Panel Testing.
    Lee J; Lee C; Park WY; Lee J
    Ann Clin Lab Sci; 2020 Sep; 50(5):625-637. PubMed ID: 33067208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome.
    Myers KA; Burgess R; Afawi Z; Damiano JA; Berkovic SF; Hildebrand MS; Scheffer IE
    Epilepsia; 2017 Feb; 58(2):e26-e30. PubMed ID: 28084635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical spectrum of mutations in SCN1A gene: severe myoclonic epilepsy in infancy and related epilepsies.
    Fujiwara T
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S223-30. PubMed ID: 16806826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of epileptic encephalopathy of the first year of life applying a customized gene panel in a group of Argentinean patients.
    Juanes M; Veneruzzo G; Loos M; Reyes G; Araoz HV; Garcia FM; Gomez G; Alonso CN; Chertkoff LP; Caraballo R
    Epilepsy Behav; 2020 Oct; 111():107322. PubMed ID: 32702657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.
    Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA
    PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare variants of small effect size in neuronal excitability genes influence clinical outcome in Japanese cases of SCN1A truncation-positive Dravet syndrome.
    Hammer MF; Ishii A; Johnstone L; Tchourbanov A; Lau B; Sprissler R; Hallmark B; Zhang M; Zhou J; Watkins J; Hirose S
    PLoS One; 2017; 12(7):e0180485. PubMed ID: 28686619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death.
    Giudicessi JR; Ye D; Kritzberger CJ; Nesterenko VV; Tester DJ; Antzelevitch C; Ackerman MJ
    Hum Mutat; 2012 Jun; 33(6):989-97. PubMed ID: 22457051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
    Hoffman-Zacharska D; Szczepanik E; Terczynska I; Goszczanska-Ciuchta A; Zalewska-Miszkurka Z; Tataj R; Bal J
    Neurol Neurochir Pol; 2015; 49(4):258-66. PubMed ID: 26188943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adults with a history of possible Dravet syndrome: an illustration of the importance of analysis of the SCN1A gene.
    Verbeek NE; van Kempen M; Gunning WB; Renier WO; Westland B; Lindhout D; Brilstra EH
    Epilepsia; 2011 Apr; 52(4):e23-5. PubMed ID: 21371021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of SCN1A-related infantile epileptic encephalopathies.
    Harkin LA; McMahon JM; Iona X; Dibbens L; Pelekanos JT; Zuberi SM; Sadleir LG; Andermann E; Gill D; Farrell K; Connolly M; Stanley T; Harbord M; Andermann F; Wang J; Batish SD; Jones JG; Seltzer WK; Gardner A; ; Sutherland G; Berkovic SF; Mulley JC; Scheffer IE
    Brain; 2007 Mar; 130(Pt 3):843-52. PubMed ID: 17347258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dravet syndrome and its mimics: Beyond SCN1A.
    Steel D; Symonds JD; Zuberi SM; Brunklaus A
    Epilepsia; 2017 Nov; 58(11):1807-1816. PubMed ID: 28880996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four novel SCN1A mutations in Turkish patients with severe myoclonic epilepsy of infancy (SMEI).
    Arlier Z; Bayri Y; Kolb LE; Erturk O; Ozturk AK; Bayrakli F; Bilguvar K; Moliterno JA; Dervent A; Demirbilek V; Yalcinkaya C; Korkmaz B; Tuysuz B; Gunel M
    J Child Neurol; 2010 Oct; 25(10):1265-8. PubMed ID: 20110217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of SCN1A-related Dravet syndrome in Denmark is 1:22,000: a population-based study from 2004 to 2009.
    Bayat A; Hjalgrim H; Møller RS
    Epilepsia; 2015 Apr; 56(4):e36-9. PubMed ID: 25778844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders.
    Komulainen-Ebrahim J; Schreiber JM; Kangas SM; Pylkäs K; Suo-Palosaari M; Rahikkala E; Liinamaa J; Immonen EV; Hassinen I; Myllynen P; Rantala H; Hinttala R; Uusimaa J
    Seizure; 2019 Jul; 69():99-104. PubMed ID: 31004928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.